Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02252796 · ClinicalTrials.gov registry record · Phase 1
Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by West Virginia University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT02252796 is a Phase 1 study that was terminated before completion, run by West Virginia University. The registered enrollment target is 1 participants.
The verdict
NCT02252796, a Phase 1 study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will help researchers test the safety of hypofractionated dose of radiotherapy (HySBst) at different dose levels before or after chemo-radiation for Non Small Cell Lung Cancer.
Interventions
- DRUG Carboplatin
- DRUG Paclitaxel
- RADIATION Hypofractionated Stereotactic Boost
- RADIATION Image-guided IMRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02252796
The ClinicalTrials.gov registry entry for NCT02252796 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Carboplatin is the first listed.
NCT02252796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02252796 about?
NCT02252796 is a clinical study titled "Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer". This study will help researchers test the safety of hypofractionated dose of radiotherapy (HySBst) at different dose levels before or after chemo-radiation for Non Small Cell Lung Cancer.
What is the current status of trial NCT02252796?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2014-07. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02252796?
The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), Hypofractionated Stereotactic Boost (RADIATION), Image-guided IMRT (RADIATION).
Who is sponsoring clinical trial NCT02252796?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.